Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM for Hepatic Encephalopathy Prevention After TIPS
NCT05128305Phase 3Unknown
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatic encephalopathy (HE) (4 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Incidence of hepatic encephalopathy at 12 weeks. Status: unknown.
02
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT05128305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05128305.